NASDAQ:KYTX

Kyverna Therapeutics Stock News

Healthcare > Biotechnology

Buy KYTX

*Your capital is at risk

$7.82

-0.0800 (-1.01%)

At Close: Jun 03, 2026

Kyverna Therapeutics Inc. May Have Violated Securities Regulations And The Schall Law Firm Wants Stakeholders With Losses To Reach Out

11:00am, Wednesday, 04'th Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Kyverna Thera

The Schall Law Firm Is Looking Into Whether Kyverna Therapeutics Inc Committed Securities Fraud And Impacted Investors Are Urged To Play A Part

11:00am, Tuesday, 03'rd Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Kyverna Thera

Load Up on Adobe Stock and These 2 Others This September, J.P. Morgan Says

07:49am, Tuesday, 03'rd Sep 2024

Adobe shares are up 31% over the past three months, having rallied after a strong quarterly earnings report that highlighted strong demand for the software developer's AI products.

Kyverna Therapeutics Inc. May Be Liable To Compensate Investors And Those With Losses Should Contact The Schall Law Firm About An Inquiry

11:00am, Monday, 02'nd Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Kyverna Thera

The Schall Law Firm Wants The Public's Contributions To An Investigation Into Whether Kyverna Therapeutics Inc Committed Securities Fraud

11:00am, Sunday, 01'st Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Kyverna Thera

Kyverna Therapeutics Inc. Is Being Looked Into For Committing Securities Law Infractions And Stakeholders Are Invited To Help The Schall Law Firm

11:00am, Saturday, 31'st Aug 2024

LOS ANGELES, CA / ACCESSWIRE / August 31, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Kyverna Therape

A Securities Fraud Inquiry Has Been Launched Into Kyverna Therapeutics Inc And The Schall Law Firm Is Seeking Investor Participation

11:00am, Friday, 30'th Aug 2024

LOS ANGELES, CA / ACCESSWIRE / August 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Kyverna Therape

The Schall Law Firm Is Investigating Whether Kyverna Therapeutics Inc. Violated Securities Laws And Shareholders Are Urged To Reach Out

11:00am, Thursday, 29'th Aug 2024

LOS ANGELES, CA / ACCESSWIRE / August 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Kyverna Therape

Investors In Kyverna Therapeutics Inc Are Encouraged To Assist The Schall Law Firm In A Securities Fraud Inquiry

11:00am, Wednesday, 28'th Aug 2024

LOS ANGELES, CA / ACCESSWIRE / August 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Kyverna Therape

The Schall Law Firm Is Looking Into Kyverna Therapeutics Inc For Possible Securities Law Violations And Shareholders Are Urged To Participate

11:00am, Tuesday, 27'th Aug 2024

LOS ANGELES, CA / ACCESSWIRE / August 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Kyverna Therape

Investors With Losses In Kyverna Therapeutics Inc Are Encouraged To Join The Schall Law Firm In A Securities Fraud Investigation

11:00am, Monday, 26'th Aug 2024

LOS ANGELES, CA / ACCESSWIRE / August 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Kyverna Therape

The Schall Law Firm Invites Shareholder Participation In An Inquiry Into Kyverna Therapeutics Inc For Securities Law Infractions

11:00am, Sunday, 25'th Aug 2024

LOS ANGELES, CA / ACCESSWIRE / August 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Kyverna Therape

Kyverna Therapeutics Inc Is Being Investigated By The Schall Law Firm For Securities Fraud And Investors Are Encouraged To Contribute

11:00am, Saturday, 24'th Aug 2024

LOS ANGELES, CA / ACCESSWIRE / August 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Kyverna Therape

The Schall Law Firm Is Looking Into Kyverna Therapeutics Inc For Potential Securities Law Violations And Impacted Shareholders Are Invited To Participate

11:00am, Friday, 23'rd Aug 2024

LOS ANGELES, CA / ACCESSWIRE / August 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Kyverna Therape

Kyverna Therapeutics Inc Is Being Investigated By The Schall Law Firm For Securities Fraud And Investors Are Encouraged To Join

11:00am, Thursday, 22'nd Aug 2024

LOS ANGELES, CA / ACCESSWIRE / August 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Kyverna Therape

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by